Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71171719 | 7117171 | 9 | F | 20160914 | 20090917 | 20160922 | EXP | CA-BRISTOL-MYERS SQUIBB COMPANY-14780902 | BRISTOL MYERS SQUIBB | 52.00 | YR | M | Y | 0.00000 | 20160922 | CN | US | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71171719 | 7117171 | 1 | PS | STAVUDINE. | STAVUDINE | 1 | Unknown | UNK | U | 20412 | |||||||||
| 71171719 | 7117171 | 2 | SS | DIDANOSINE. | DIDANOSINE | 1 | Unknown | UNK | U | 0 | POWDER FOR ORAL SOLUTION | ||||||||
| 71171719 | 7117171 | 3 | SS | SUSTIVA | EFAVIRENZ | 1 | Oral | UNK | U | 0 | CAPSULE | ||||||||
| 71171719 | 7117171 | 4 | SS | ZIDOVUDINE. | ZIDOVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 5 | SS | LAMIVUDINE. | LAMIVUDINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 6 | SS | INDINAVIR SULFATE | INDINAVIR SULFATE | 1 | Oral | FORM: CAPSULES. | U | 0 | |||||||||
| 71171719 | 7117171 | 7 | SS | NORVIR | RITONAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 8 | SS | SAQUINAVIR | SAQUINAVIR | 1 | Oral | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 9 | SS | DARUNAVIR | DARUNAVIR | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 71171719 | 7117171 | 10 | SS | ABACAVIR SULFATE. | ABACAVIR SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 11 | SS | LOPINAVIR | LOPINAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 12 | SS | NEVIRAPINE. | NEVIRAPINE | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 13 | SS | ENFUVIRTIDE | ENFUVIRTIDE | 1 | Subcutaneous | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 14 | SS | TENOFOVIR DISOPROXIL FUMARATE. | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 15 | SS | DELAVIRDINE | DELAVIRDINE | 1 | Unknown | UNK | U | 0 | TABLET | ||||||||
| 71171719 | 7117171 | 16 | SS | RALTEGRAVIR. | RALTEGRAVIR | 1 | Oral | 400 MG, UNK | U | 0 | 400 | MG | TABLET | ||||||
| 71171719 | 7117171 | 17 | SS | ETRAVIRINE | ETRAVIRINE | 1 | Oral | UNK | U | 0 | TABLET | ||||||||
| 71171719 | 7117171 | 18 | SS | VIRACEPT | NELFINAVIR MESYLATE | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 19 | SS | LOPINAVIR + RITONAVIR | LOPINAVIRRITONAVIR | 1 | Unknown | UNK | U | 0 | |||||||||
| 71171719 | 7117171 | 20 | SS | INTELENCE | ETRAVIRINE | 1 | Oral | U | 0 | ||||||||||
| 71171719 | 7117171 | 21 | SS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
| 71171719 | 7117171 | 22 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Unknown | U | 0 | TABLET | |||||||||
| 71171719 | 7117171 | 23 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 71171719 | 7117171 | 1 | HIV infection |
| 71171719 | 7117171 | 2 | HIV infection |
| 71171719 | 7117171 | 3 | HIV infection |
| 71171719 | 7117171 | 4 | HIV infection |
| 71171719 | 7117171 | 5 | HIV infection |
| 71171719 | 7117171 | 6 | HIV infection |
| 71171719 | 7117171 | 7 | HIV infection |
| 71171719 | 7117171 | 8 | HIV infection |
| 71171719 | 7117171 | 9 | HIV infection |
| 71171719 | 7117171 | 10 | HIV infection |
| 71171719 | 7117171 | 11 | HIV infection |
| 71171719 | 7117171 | 12 | HIV infection |
| 71171719 | 7117171 | 13 | HIV infection |
| 71171719 | 7117171 | 14 | HIV infection |
| 71171719 | 7117171 | 15 | HIV infection |
| 71171719 | 7117171 | 16 | HIV infection |
| 71171719 | 7117171 | 17 | HIV infection |
| 71171719 | 7117171 | 18 | HIV infection |
| 71171719 | 7117171 | 19 | HIV infection |
| 71171719 | 7117171 | 20 | HIV infection |
| 71171719 | 7117171 | 21 | HIV infection |
| 71171719 | 7117171 | 22 | HIV infection |
| 71171719 | 7117171 | 23 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 71171719 | 7117171 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 71171719 | 7117171 | Diplopia | |
| 71171719 | 7117171 | Eyelid ptosis | |
| 71171719 | 7117171 | Lipodystrophy acquired | |
| 71171719 | 7117171 | Mitochondrial toxicity | |
| 71171719 | 7117171 | Progressive external ophthalmoplegia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 71171719 | 7117171 | 10 | 200802 | 0 |